Загрузка...
Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy
BACKGROUND: Statins may reduce the risk of first and recurrent venous thromboembolism (VTE). No data are available on their potential benefit in patients treated with the oral anticoagulant rivaroxaban. METHODS: The EINSTEIN DVT/PE and EINSTEIN Extension studies compared rivaroxaban with standard of...
Сохранить в:
| Опубликовано в: : | Thromb J |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4334416/ https://ncbi.nlm.nih.gov/pubmed/25698905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-9560-12-26 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|